This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dubey, R. K. Articles by Jackson, E. K. Search for Related Content PubMed PubMed Citation Articles by Dubey, R. K. Articles by Jackson, E. K.

(Hypertension. 1996;27:786-793.)
© 1996 American Heart Association, Inc.

Articles

Adenosine Inhibits Growth of Rat Aortic Smooth Muscle Cells

Possible Role of A2b Receptor

Raghvendra K. Dubey; Delbert G. Gillespie; Kazuhiro Osaka; Fumio Suzuki; Edwin K. Jackson

From the Center for Clinical Pharmacology, Laboratory of Cell Biology and Physiology, Departments of Medicine (R.K.D., D.G.G., K.O.) and Pharmacology (E.K.J.), University of Pittsburgh (Pa) Medical Center, and Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co, Sunto-Gun, Shizuoka-Ken, Japan (F.S.).

Correspondence to Dr Raghvendra K. Dubey, Center for Clinical Pharmacology, Department of Medicine, 623 Scaife Hall, 200 Lothrop St, University of Pittsburgh Medical Center, Pittsburgh, PA 15213-2582.

Abstract Abnormal growth of vascular smooth muscle cells (SMC) is frequently associated with hypertension and atherosclerosis, and homeostasis within a normal vessel is maintained by the balanced generation of both vasoconstrictors and vasodilators. Moreover, several endogenous vasoconstricting factors induce SMC growth, whereas several vasodilators inhibit SMC growth. Inasmuch as adenosine is a potent vasodilator, it is possible that it too could inhibit SMC growth. Hence, the effects of adenosine (10^-8 to 10^-3 mol/L), 2-chloroadenosine (a stable analogue of adenosine; 10^-8 to 10^-3 mol/L), and 8-bromo-cAMP (10^-8 to 10^-3 mol/L) on fetal calf serum (FCS; 2.5%)–induced growth of rat aortic SMC were evaluated. Growth was analyzed by assaying DNA synthesis (thymidine incorporation in SMC pulsed for 4 hours with 1 µCi/mL [³H]thymidine) and cell proliferation (change in cell number). Growth-arrested SMC were treated with 2.5% FCS in the presence and absence of adenosine, 2-chloroadenosine, or 8-bromo-cAMP for 24 hours for DNA synthesis or 4 days for cell proliferation. All three substances inhibited DNA synthesis and cell proliferation in a concentration-dependent manner. Compared with adenosine, 2-chloroadenosine was more potent in inhibiting growth. The inhibitory effects of 2-chloroadenosine were reversed by KF17837 (a specific A₂ receptor antagonist) but not by DPCPX (a specific A₁ receptor antagonist). Furthermore, the inhibitory effects of 2-chloroadenosine were not mimicked by CGS21680 (an A_2a receptor agonist), and the effects of N⁶-cyclopentyladenosine (CPA; an A₁ receptor agonist) were not markedly more potent than those of 2-chloroadenosine, suggesting that the inhibitory effects of adenosine are possibly mediated via A_2b receptors. These studies provide evidence that adenosine inhibits SMC growth and suggest that a decrease in local levels of adenosine may initiate SMC growth and contribute to the vascular remodeling process observed in hypertension and atherosclerosis.

Key Words: adenosine • muscle, smooth, vascular • atherosclerosis • hyperplasia

This article has been cited by other articles:

				A. N. Clark, R. Youkey, X. Liu, L. Jia, R. Blatt, Y.-J. Day, G. W. Sullivan, J. Linden, and A. L. Tucker A1 Adenosine Receptor Activation Promotes Angiogenesis and Release of VEGF From Monocytes Circ. Res., November 26, 2007; 101(11): 1130 - 1138. [Abstract] [Full Text] [PDF]

				J. Shen, S. P. Halenda, M. Sturek, and P. A. Wilden Novel Mitogenic Effect of Adenosine on Coronary Artery Smooth Muscle Cells: Role for the A1 Adenosine Receptor Circ. Res., May 13, 2005; 96(9): 982 - 990. [Abstract] [Full Text] [PDF]

				G. Burnstock Purinergic Signaling and Vascular Cell Proliferation and Death Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 364 - 373. [Abstract] [Full Text] [PDF]

				B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552. [Abstract] [Full Text] [PDF]

				E. K. Jackson and R. K. Dubey Role of the extracellular cAMP-adenosine pathway in renal physiology Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612. [Abstract] [Full Text] [PDF]

				R. K. Dubey, D. G. Gillespie, Z. Mi, and E. K. Jackson Endogenous Cyclic AMP-Adenosine Pathway Regulates Cardiac Fibroblast Growth Hypertension, April 1, 2001; 37(4): 1095 - 1100. [Abstract] [Full Text] [PDF]

				R. K. Dubey, D. G. Gillespie, Z. Mi, and E. K. Jackson Cardiac Fibroblasts Express the cAMP-Adenosine Pathway Hypertension, September 1, 2000; 36(3): 337 - 342. [Abstract] [Full Text] [PDF]

				M.-L. Peyot, A.-P. Gadeau, F. Dandre, I. Belloc, F. Dupuch, and C. Desgranges Extracellular Adenosine Induces Apoptosis of Human Arterial Smooth Muscle Cells via A2b-Purinoceptor Circ. Res., January 7, 2000; 86(1): 76 - 85. [Abstract] [Full Text] [PDF]

				R. K. Dubey, D. G. Gillespie, Z. Mi, M. Rosselli, P. J. Keller, and E. K. Jackson Estradiol Inhibits Smooth Muscle Cell Growth in Part by Activating the cAMP-Adenosine Pathway Hypertension, January 1, 2000; 35(1): 262 - 266. [Abstract] [Full Text] [PDF]

				R. K. Dubey, D. G. Gillespie, H. Shue, and E. K. Jackson A2B Receptors Mediate Antimitogenesis in Vascular Smooth Muscle Cells Hypertension, January 1, 2000; 35(1): 267 - 272. [Abstract] [Full Text] [PDF]

				K. W. Hong, H. K. Shin, H. H. Kim, J. M. Choi, B. Y. Rhim, and W. S. Lee Metabolism of cAMP to adenosine: role in vasodilation of rat pial artery in response to hypotension Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H376 - H382. [Abstract] [Full Text] [PDF]

				V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF]

				R. K. Dubey, D. G. Gillespie, and E. K. Jackson Cyclic AMP-Adenosine Pathway Induces Nitric Oxide Synthesis in Aortic Smooth Muscle Cells Hypertension, January 1, 1998; 31(1): 296 - 302. [Abstract] [Full Text] [PDF]

				R. K. Dubey, D. G. Gillespie, Z. Mi, and E. K. Jackson Adenosine Inhibits Growth of Human Aortic Smooth Muscle Cells Via A2B Receptors Hypertension, January 1, 1998; 31(1): 516 - 521. [Abstract] [Full Text] [PDF]

				I. Feoktistov and I. Biaggioni Adenosine A2B Receptors Pharmacol. Rev., December 1, 1997; 49(4): 381 - 402. [Abstract] [Full Text] [PDF]

				U. Ikeda, K. Kurosaki, K.-i. Ohya, and K. Shimada Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cells Cardiovasc Res, July 1, 1997; 35(1): 168 - 174. [Abstract] [Full Text] [PDF]

				R. K. Dubey, D. G. Gillespie, Z. Mi, F. Suzuki, and E. K. Jackson Smooth Muscle Cell–Derived Adenosine Inhibits Cell Growth Hypertension, March 1, 1996; 27(3): 766 - 773. [Abstract] [Full Text]